Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1969 4
1970 3
1972 1
1973 1
1974 5
1975 4
1976 2
1977 5
1978 5
1979 3
1980 2
1981 5
1982 8
1983 7
1984 7
1985 3
1986 10
1987 12
1988 7
1989 17
1990 19
1991 8
1992 13
1993 9
1994 11
1995 11
1996 10
1997 9
1998 12
1999 8
2000 11
2001 5
2002 11
2003 16
2004 21
2005 15
2006 14
2007 15
2008 22
2009 28
2010 21
2011 24
2012 40
2013 53
2014 66
2015 62
2016 51
2017 75
2018 61
2019 63
2020 62
2021 62
2022 42
2023 39
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

1,001 results

Results by year

Filters applied: . Clear all
Page 1
Glioblastoma: Overview of Disease and Treatment.
Davis ME. Davis ME. Clin J Oncol Nurs. 2016 Oct 1;20(5 Suppl):S2-8. doi: 10.1188/16.CJON.S1.2-8. Clin J Oncol Nurs. 2016. PMID: 27668386 Free PMC article. Review.
Significant advances in the understanding of the molecular pathology of GBM and associated cell signaling pathways have opened opportunities for new therapies for recurrent and newly diagnosed disease. ...METHODS: A brief review of GBM, treatment options, and a look …
Significant advances in the understanding of the molecular pathology of GBM and associated cell signaling pathways have opened opport …
Advances in the management of glioblastoma.
Ma R, Taphoorn MJB, Plaha P. Ma R, et al. J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1103-1111. doi: 10.1136/jnnp-2020-325334. Epub 2021 Jun 23. J Neurol Neurosurg Psychiatry. 2021. PMID: 34162730 Review.
Glioblastoma (GB) is the most common and most malignant primary brain tumour in adults. Despite much effort, gold standard therapy has not changed since the introduction of adjuvant temozolomide in 2005 and prognosis remains poor. ...We review the current best pract …
Glioblastoma (GB) is the most common and most malignant primary brain tumour in adults. Despite much effort, gold standard therapy …
The management of low-grade gliomas in adults.
Morshed RA, Young JS, Hervey-Jumper SL, Berger MS. Morshed RA, et al. J Neurosurg Sci. 2019 Aug;63(4):450-457. doi: 10.23736/S0390-5616.19.04701-5. Epub 2019 Mar 27. J Neurosurg Sci. 2019. PMID: 30916536 Review.
Low grade gliomas (LGGs) are WHO grade II tumors that affect mostly adult patients and include diffuse astrocytomas and oligodendrogliomas. ...In this review, we summarize the defining molecular features, important prognostic factors, recommended pre-operative imaging work …
Low grade gliomas (LGGs) are WHO grade II tumors that affect mostly adult patients and include diffuse astrocytomas and oligodendrogl …
Molecular Mechanisms of Treatment Resistance in Glioblastoma.
Ou A, Yung WKA, Majd N. Ou A, et al. Int J Mol Sci. 2020 Dec 31;22(1):351. doi: 10.3390/ijms22010351. Int J Mol Sci. 2020. PMID: 33396284 Free PMC article. Review.
Glioblastoma is the most common malignant primary brain tumor in adults and is almost invariably fatal. Despite our growing understanding of the various mechanisms underlying treatment failure, the standard-of-care therapy has not changed over the last two de …
Glioblastoma is the most common malignant primary brain tumor in adults and is almost invariably fatal. Despite our growing understan …
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.
Weller M, van den Bent M, Tonn JC, Stupp R, Preusser M, Cohen-Jonathan-Moyal E, Henriksson R, Le Rhun E, Balana C, Chinot O, Bendszus M, Reijneveld JC, Dhermain F, French P, Marosi C, Watts C, Oberg I, Pilkington G, Baumert BG, Taphoorn MJB, Hegi M, Westphal M, Reifenberger G, Soffietti R, Wick W; European Association for Neuro-Oncology (EANO) Task Force on Gliomas. Weller M, et al. Lancet Oncol. 2017 Jun;18(6):e315-e329. doi: 10.1016/S1470-2045(17)30194-8. Epub 2017 May 5. Lancet Oncol. 2017. PMID: 28483413 Free article. Review.
The European Association for Neuro-Oncology guideline provides recommendations for the clinical care of adult patients with astrocytic and oligodendroglial gliomas, including glioblastomas. ...The recommendations are a resource for professionals involved in the mana …
The European Association for Neuro-Oncology guideline provides recommendations for the clinical care of adult patients with as …
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Nabors LB, Portnow J, Ahluwalia M, Baehring J, Brem H, Brem S, Butowski N, Campian JL, Clark SW, Fabiano AJ, Forsyth P, Hattangadi-Gluth J, Holdhoff M, Horbinski C, Junck L, Kaley T, Kumthekar P, Loeffler JS, Mrugala MM, Nagpal S, Pandey M, Parney I, Peters K, Puduvalli VK, Robins I, Rockhill J, Rusthoven C, Shonka N, Shrieve DC, Swinnen LJ, Weiss S, Wen PY, Willmarth NE, Bergman MA, Darlow SD. Nabors LB, et al. J Natl Compr Canc Netw. 2020 Nov 2;18(11):1537-1570. doi: 10.6004/jnccn.2020.0052. J Natl Compr Canc Netw. 2020. PMID: 33152694
The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas to metastatic brain disease. ...Treatment of brain metastases, the most common intracranial tumors i …
The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of adult CNS cancers ranging from noninvasive and su …
Targeted therapies for glioblastoma treatment.
Smolarska A, Pruszynska I, Wasylko W, Godlewska K, Markowska M, Rybak A, Botther J, Kucharzewska P, Nowakowska J, Szeliga J, Kubiak M, Gorczak M, Krol M. Smolarska A, et al. J Physiol Pharmacol. 2023 Jun;74(3). doi: 10.26402/jpp.2023.3.01. Epub 2023 Aug 30. J Physiol Pharmacol. 2023. PMID: 37661178 Free article. Review.
Additionally, the review explores the utilization of nanocarriers capable of surmounting the formidable obstacle of the blood-brain barrier, enabling efficient drug delivery. Cell therapies represent another promising approach, with dendritic cells, chimeric antigen …
Additionally, the review explores the utilization of nanocarriers capable of surmounting the formidable obstacle of the blood-brain barrier, …
Treatment of Glioblastoma.
Nam JY, de Groot JF. Nam JY, et al. J Oncol Pract. 2017 Oct;13(10):629-638. doi: 10.1200/JOP.2017.025536. J Oncol Pract. 2017. PMID: 29020535 Review.
Glioblastoma is the most common and most aggressive form of primary brain tumor in adults and contributes to high social and medical burden as a result of its incurable nature and significant neurologic morbidity. ...We review updates in management of newly diagnosed and r …
Glioblastoma is the most common and most aggressive form of primary brain tumor in adults and contributes to high social and medical …
Glioblastoma Treatment in the Elderly.
Okada M, Miyake K, Tamiya T. Okada M, et al. Neurol Med Chir (Tokyo). 2017 Dec 15;57(12):667-676. doi: 10.2176/nmc.ra.2017-0009. Epub 2017 Oct 30. Neurol Med Chir (Tokyo). 2017. PMID: 29081442 Free PMC article. Review.
Surgery should be considered as the first-line treatment even for elderly patients, and maximum safe resection is recommended if feasible. Concurrently, radiotherapy is the standard adjuvant therapy. Hypofractionated radiotherapy (e.g., 40 Gy/15 Fr) is suitable for elderly …
Surgery should be considered as the first-line treatment even for elderly patients, and maximum safe resection is recommended if feasible. C …
Unlocking Glioblastoma Vulnerabilities with CRISPR-Based Genetic Screening.
Fang Y, Li X, Tian R. Fang Y, et al. Int J Mol Sci. 2024 May 23;25(11):5702. doi: 10.3390/ijms25115702. Int J Mol Sci. 2024. PMID: 38891890 Free PMC article. Review.
Glioblastoma (GBM) is the most common malignant brain tumor in adults. Despite advancements in treatment, the prognosis for patients with GBM remains poor due to its aggressive nature and resistance to therapy. ...We highlight how these approaches have been used to …
Glioblastoma (GBM) is the most common malignant brain tumor in adults. Despite advancements in treatment, the prognosis for patients …
1,001 results